Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC C2B8, rituximab)

Annals of Hematology

Volumn 77, Issue 1-2, 1998, Pages 89-91

  Jensen, M ^a   Winkler, U ^a   Manzke, O ^a   Diehl, V ^a   Engert, A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Chronic lymphocytic leukemia; IDEC C2B8; Immunotherapy; Rituximab; Tumor lysis syndrome

Indexed keywords

CD20 ANTIGEN; MONOCLONAL ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B CELL LEUKEMIA; CASE REPORT; CHILL; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; FEVER; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; THROAT DISEASE;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LYMPHOCYTOSIS; TUMOR LYSIS SYNDROME;

EID: 0031664666     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050419     Document Type: Article

References (7)

1. Reff ME, Carner K, Chambers KS, Chinn, PC, Leonard JE, Raah R, Newmann RA, Hamma N, Anderson DR (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435-445
2. Maloney D, Grillo-LóPez A, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon K A, Liles T-M, Dallaire BK, Wey K, Royston I, Davis T, Levy R (1997) IDEC-C2B8 (Rituximab) Anti CD-20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma. Blood 90:2188-2195
3. McLaughlin P, Cabanillas F, Grilló-Lopez AJ, Link BK, Levy R, Czuzmann M, Heymann MR, Williams M, Jain V, Bence-Bruckler I, Ho AD, Lister J, Rosenberg J, Dallaire BK, Shen D (1996) IDEC-C2B8 anti CD20 antibody: Final report on a phase III pivotal trial in patients with relapsed low-grade or follicular lymphoma. Blood 88 suppl 1:349 (abstr)
4. Maloney DD, Grillo-López AJ, Bodkin DJ, White CA, Liles T-M, Royston I, Varne, C, Rosenberg J, Levy R (1997) RITUXIMAB: Results of a phase I multiple-dose trial in patients with relapsed Non-Hodgkin's Lymphoma. J Clin One 15:3266-3274
5. Nadler LM, Stashenko P, Hardy R, Kaplan, WD. Button LN, Kufe DW, Antmann KH, Schlossmann SF (1980) Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma associated antigen. Cancer Res 40:3147-3154
6. Riechmann L, Clark M, Waldmann H, Winter G (1988) Reshaping human antibodies for therapy. Nature 332:323-327
7. Österborg A, Dyer MJS, Bunjes D, Pangalis GA, Bastion Y, Catovsky D, Mellstedt H for the European Study Group of CAMPATH-IH (1997) Treatment in Chronic lymphocytic Leukemia: Phase II Multicenter Study of Human CD52 Antibody in Previously Treated Chronic Lymphocytic Leukaemia. J Clin Onc 15:1567-1574